Literature DB >> 14960748

B-type natriuretic peptide - a biomarker for all seasons?

Daniel B Mark, G Michael Felker.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14960748     DOI： 10.1056/NEJMe038233

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Safe use of brain natriuretic protein to rule out the diagnosis of heart failure depends on the selection of cut off value.

Authors:  S G Williams; L L Ng; R J O'Brien; D Barker; Y-F Li; L-B Tan
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

2.  Pre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study.

Authors:  Simcha R Meisel; James L Januzzi; Margarita Medvedovski; Moshe Sharist; Michael Shochat; Jalal Ashkar; Pavel Peschansky; Shmuel Bar Haim; David S Blondheim; Michael Glikson; Avraham Shotan
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

3.  Diagnostic accuracy of tissue Doppler echocardiography for patients with acute heart failure.

Authors:  C-H Huang; M-S Tsai; C-C Hsieh; T-D Wang; W-T Chang; W-J Chen
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

Review 4.  Use of multiple biomarkers in heart failure.

Authors:  Larry A Allen
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

5.  Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.

Authors:  Paul M McKie; Richard J Rodeheffer; Alessandro Cataliotti; Fernando L Martin; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Margaret M Redfield; John C Burnett
Journal:  Hypertension       Date:  2006-04-03       Impact factor: 10.190

6.  Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea.

Authors:  Lars Lüthje; Bernd Renner; Roger Kessels; Dirk Vollmann; Tobias Raupach; Bart Gerritse; Selcuk Tasci; Jörg O Schwab; Markus Zabel; Dieter Zenker; Peter Schott; Gerd Hasenfuss; Christina Unterberg-Buchwald; Stefan Andreas
Journal:  Eur J Heart Fail       Date:  2009-01-12       Impact factor: 15.534

7.  Changes in N-terminal pro B-type natriuretic peptide concentration: comparative study of percutaneous transluminal coronary angioplasty and off-pump coronary artery bypass graft.

Authors:  Hyun Koo Kim; Hark Jei Kim; Jin Won Kim; Young-sang Sohn; Young Ho Choi
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

8.  Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.

Authors:  Samo Zver; Vesna Zadnik; Matjaz Bunc; Polona Rogel; Peter Cernelc; Mirta Kozelj
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

Review 9.  Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Authors:  Jun R Chiong; Geoffrey T Jao; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

10.  The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events.

Authors:  Hirofumi Ueno; Masafumi Nakayama; Sunao Kojima; Kenichi Kusuhara; Yasuhiro Nagayoshi; Megumi Yamamuro; Tsunenori Nishijima; Hiroki Usuku; Kouichi Kaikita; Hitoshi Sumida; Hiroshige Yamabe; Seigo Sugiyama; Michihiro Yoshimura; Hisao Ogawa
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.